-transparent.png){kind=logo}
The activities of serum acid ribonuclease (RNase) were determined in patients with malignant neoplasm or with renal failure. The levels were markedly increased in myelogenous leukemia and renal failure, and only slightly increased in solid cancers, lymphoid malignancies and multiple myeloma. These increases correlated significantly with serum LDH activity in myelogenous leukemia and with creatinine levels in other malignancies or renal failure. The acid RNase content of granulocytes was 22.7-fold higher than that of lymphocytes. The increase of serum acid RNase may suggest an increased granulocyte destruction in myelogenous leukemia and a reduced glomerular filtration in other malignant neoplasms and renal failure.
K Akagi, and
H Tsuji, and
E Kajiwara, and
K Murai, and
T Shikata
January 1986,
Acta medica Polona,
K Akagi, and
H Tsuji, and
E Kajiwara, and
K Murai, and
T Shikata
March 1962,
Canadian Medical Association journal,
K Akagi, and
H Tsuji, and
E Kajiwara, and
K Murai, and
T Shikata
January 1959,
Tumori,
K Akagi, and
H Tsuji, and
E Kajiwara, and
K Murai, and
T Shikata
January 1983,
Radioisotopes,
K Akagi, and
H Tsuji, and
E Kajiwara, and
K Murai, and
T Shikata
January 1991,
Zhonghua fu chan ke za zhi,
K Akagi, and
H Tsuji, and
E Kajiwara, and
K Murai, and
T Shikata
September 1984,
Fukuoka igaku zasshi = Hukuoka acta medica,
K Akagi, and
H Tsuji, and
E Kajiwara, and
K Murai, and
T Shikata
April 1986,
British journal of anaesthesia,
K Akagi, and
H Tsuji, and
E Kajiwara, and
K Murai, and
T Shikata
November 1986,
Archives of dermatology,
K Akagi, and
H Tsuji, and
E Kajiwara, and
K Murai, and
T Shikata
June 1997,
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
K Akagi, and
H Tsuji, and
E Kajiwara, and
K Murai, and
T Shikata
September 1963,
Gazzetta internazionale di medicina e chirurgia,
